Contaminant in the recalled unfractionated heparin preparations: where is the problem?

Clin Appl Thromb Hemost. 2008 Jul;14(3):261-6. doi: 10.1177/1076029608317932. Epub 2008 Jun 19.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Animals
  • Anticoagulants / adverse effects*
  • Anticoagulants / isolation & purification
  • Anticoagulants / standards
  • Drug Contamination* / legislation & jurisprudence
  • Drug Contamination* / prevention & control
  • Drug and Narcotic Control / legislation & jurisprudence
  • Heparin / adverse effects*
  • Heparin / isolation & purification
  • Heparin / standards
  • Humans
  • Quality Control
  • Sus scrofa
  • United States
  • United States Food and Drug Administration

Substances

  • Anticoagulants
  • Heparin